Room: Ibiza

Tuesday 31 May

10:00-11:30

Parallel 5b: Cell and gene therapy of Neural diseases

Chair: Juan José Toledo-Aral, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla


10:00    Benedikt Berninger, Institute of Psychiatry, Psychology & Neuroscience Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King's College London  

INV30    Advancing in vivo glia-to-neuron reprogramming as an innovative approach for brain repair: promises, disappointments, and breakthroughs

ABSTRACT >


10:30    Juan Ruiz, Forge Therapeutics 

INV31    The RESKUE Trial - a Phase 1/2 Clinical Trial for Patients with Krabbe Disease


11:00   Sergi Verdés, Institut de Neurociències (INc), Universitat Autònoma de Barcelona (UAB)

OR11    Gene therapy for ALS by specifically overexpressing a pleiotropic chronokine, secreted α-Klotho (s-KL), in skeletal muscles

ABSTRACT >


11:15    Nieves Iria Domínguez-García, Instituto de Biomedicina de Sevilla (IBiS)

OR12    Pathophysiological alterations of regulatory T cells in Parkinson's disease and generation of aSyn-CAR-Tregs as a novel therapeutic approach

ABSTRACT >

Transparent Logo.png